Title |
Canadian guidelines for rhinosinusitis: practical tools for the busy clinician
|
---|---|
Published in |
BMC Ear, Nose and Throat Disorders, February 2012
|
DOI | 10.1186/1472-6815-12-1 |
Pubmed ID | |
Authors |
Shaun Kilty |
Abstract |
Acute bacterial rhinosinusitis (ABRS) and chronic rhinosinusitis (CRS) frequently present in clinical practice. Guidelines for management of these conditions have been published extensively in the past. However, a set of guidelines that addressed issues specific to the Canadian environment while offering clear guidance for first-line clinicians was needed, and resulted in the recent publication of Canadian clinical practice guidelines for ABRS and CRS. In addition to addressing issues specific to Canadian physicians, the presented guidelines are applicable internationally, and offer single algorithms for the diagnosis and management of ABRS and CRS, as well as expert opinion in areas that do not have an extensive evidence base. This commentary presents major points from the guidelines, as well as the intended impact of the guidelines on clinical practice.See guidelines at: http://www.aacijournal.com/content/7/1/2. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 13% |
Kuwait | 1 | 13% |
Canada | 1 | 13% |
United States | 1 | 13% |
Hungary | 1 | 13% |
Unknown | 3 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Scientists | 3 | 38% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 4% |
Colombia | 1 | 4% |
Ecuador | 1 | 4% |
Unknown | 23 | 88% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 15% |
Student > Bachelor | 4 | 15% |
Student > Postgraduate | 3 | 12% |
Researcher | 3 | 12% |
Other | 2 | 8% |
Other | 5 | 19% |
Unknown | 5 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 69% |
Neuroscience | 1 | 4% |
Nursing and Health Professions | 1 | 4% |
Unknown | 6 | 23% |